![]() |
|
|
Vol. 293, Issue 2, 522-529, May 2000
Research Laboratories, Nippon Shinyaku Co., Ltd., Nishiohji Hachijo
Minami-ku, Kyoto, Japan
The hypoxic injury was induced in rat cerebrocortical slices by the
exposure to hypoxia for 45 min in the absence or presence of 3 mM
glucose, followed by reoxygenation for 5 h. The injury was more
pronounced in the absence of glucose (severe hypoxic injury) than in
the presence of glucose (mild hypoxic injury). A novel
Na+/Ca2+ channel blocker, NS-7
[4-(4-fluorophenyl)-2-methyl-6-(5-piperidinopentyloxy) pyrimidine
hydrochloride], at 3 to 30 µM inhibited preferentially the severe
hypoxic injury, whereas MK-801,
-conotoxin GVIA (
-CTX), and
NG-nitro-L-arginine methylester
suppressed preferentially the mild hypoxic injury. The extracellular
cyclic GMP formation, a marker of nitric oxide synthesis, was enhanced
during hypoxia, although the extent was greater in the
absence of glucose. As observed in the hypoxic injury, NS-7
preferentially inhibited the cyclic GMP formation induced by severe
hypoxic insults, whereas MK-801 or
-CTX reduced it under mild
hypoxic condition. When 30 to 50 mM KCl was applied to normoxic slices,
a concentration-dependent increase in the extracellular cyclic GMP
formation was observed. NS-7 blocked the cyclic GMP formation induced
by 50 mM KCl but not by 30 to 40 mM KCl, whereas
-CTX suppressed
only the 30 mM KCl-evoked response. In primary neuronal culture, NS-7
reversed KCl-induced increase in intracellular Ca2+ in
which the inhibition was marked when the KCl concentration was
increased. These findings suggest that NS-7, unlike other neuroprotective compounds used in this study, is more effective in
severe hypoxic injury. The highly voltage-dependent Ca2+
channel blockade may contribute to the mode of neuroprotective action
of NS-7.
This article has been cited by other articles:
![]() |
E. Shi, T. Kazui, X. Jiang, N. Washiyama, K. Suzuki, K. Yamashita, and H. Terada NS-7, a novel Na+/Ca2+ channel blocker, prevents neurologic injury after spinal cord ischemia in rabbits J. Thorac. Cardiovasc. Surg., February 1, 2005; 129(2): 364 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Aoki, M. Tamura, Y. Itoh, T. Seto, K. Nonaka, H. Mukai, and Y. Ukai Effective Plasma Concentration of a Novel Na+/Ca2+ Channel Blocker NS-7 for Its Cerebroprotective Actions in Rats with a Transient Middle Cerebral Artery Occlusion J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 306 - 311. [Abstract] [Full Text] |
||||